Tefferi A - Search Results

1

JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival.

Tefferi A, Lasho TL, Patnaik MM, Finke CM, Hussein K, Hogan WJ, Elliott MA, Litzow MR, Hanson CA, Pardanani A. Tefferi A, et al. Leukemia. 2010 Jan;24(1):105-9. doi: 10.1038/leu.2009.225. Epub 2009 Oct 22. Leukemia. 2010. PMID: 19847199

2

Demonstration of clonality, by X-linked DNA analysis, in chronic natural killer cell lymphocytosis and successful therapy with oral cyclophosphamide.

Tefferi A, Greipp PR, Leibson PJ, Thibodeau SN. Tefferi A, et al. Leukemia. 1992 May;6(5):477-80. Leukemia. 1992. PMID: 1350651

3

Acute lymphocytic leukemia in adults: a retrospective study and analysis of current management options.

Ho TC, Tefferi A, Su JQ, Litzow MR, Hoagland HC, Noël P. Ho TC, et al. Among authors: tefferi a. Mayo Clin Proc. 1994 Oct;69(10):937-48. doi: 10.1016/s0025-6196(12)61817-5. Mayo Clin Proc. 1994. PMID: 7934190

4

Bone marrow transplantation for chronic myelogenous leukemia.

Litzow MR, Tefferi A. Litzow MR, et al. Among authors: tefferi a. Blood. 1994 May 1;83(9):2752-3. Blood. 1994. PMID: 8167356 Free article. No abstract available.

5

Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study.

Dhodapkar M, Tefferi A, Su J, Phyliky RL. Dhodapkar M, et al. Among authors: tefferi a. Leukemia. 1993 Aug;7(8):1232-5. Leukemia. 1993. PMID: 8350623

6

Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells.

Okuno SH, Tefferi A, Hanson CA, Katzmann JA, Li CY, Witzig TE. Okuno SH, et al. Among authors: tefferi a. Br J Haematol. 1996 Jun;93(4):810-2. Br J Haematol. 1996. PMID: 8703808

7

Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia.

Tefferi A, Bartholmai BJ, Witzig TE, Li CY, Hanson CA, Phyliky RL. Tefferi A, et al. Am J Clin Pathol. 1996 Oct;106(4):457-61. doi: 10.1093/ajcp/106.4.457. Am J Clin Pathol. 1996. PMID: 8853032

8

Current perspective in agnogenic myeloid metaplasia.

Tefferi A, Silverstein MN. Tefferi A, et al. Leuk Lymphoma. 1996 Sep;22 Suppl 1:169-71. doi: 10.3109/10428199609074375. Leuk Lymphoma. 1996. PMID: 8951788 Review.

9

Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells.

Tefferi A, Hanson CA, Kurtin PJ, Katzmann JA, Dalton RJ, Nichols WL. Tefferi A, et al. Br J Haematol. 1997 Mar;96(4):850-3. doi: 10.1046/j.1365-2141.1997.d01-2088.x. Br J Haematol. 1997. PMID: 9074430 Free article.

10

Chronic granulocytic leukemia: recent information on pathogenesis, diagnosis, and disease monitoring.

Tefferi A, Litzow MR, Noel P, Dewald GW. Tefferi A, et al. Mayo Clin Proc. 1997 May;72(5):445-52. doi: 10.4065/72.5.445. Mayo Clin Proc. 1997. PMID: 9146688 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,188 results

Search Page

Filters